Product Program year 2020 Source: CMS Open Payments

(810) Chenodal

Drug Hepatology

NDC 45043-0876-4

Open in the dashboard

General payments

$332,813

15 payments

Research payments

$1,017,694

420 payments

Through program year 2020, $332,813 in general payments and $1,017,694 in research payments were reported against (810) Chenodal (Hepatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $2,000 1
2020 Research $599,692 233
2019 General $330,813 14
2019 Research $418,001 187

Breakdown

Who paid General payments · program years 2019–2020
  1. Retrophin, Inc. $332,813 15 payments
Top recipients General payments · program year 2020
  1. Janine Collinge Pediatric Ophthalmology and Strabismus Specialist · Rocky Hill, CT $2,000 100% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Pediatric Ophthalmology and Strabismus Specialist Ophthalmology $2,000 100% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Connecticut $2,000 100% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

15 general · 420 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record